VENTURE LIFE GROUP PLC Logo

VENTURE LIFE GROUP PLC

Develops, manufactures, and distributes consumer self-care products and medical devices globally.

VLG | IL

Overview

Corporate Details

ISIN(s):
GB00BFPM8908 (+2 more)
LEI:
213800S8CZUPLAB2KC70
Country:
United Kingdom
Address:
12 THE COURTYARD, RG12 2XB BRACKNELL
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Venture Life Group PLC is an international consumer self-care company that develops, manufactures, and distributes products for the global market. The company's portfolio focuses on non-prescription items, including medical devices and food supplements, designed to meet the growing demand for preventative wellness and self-medication. It operates an extensive distribution network with over 200 partners in more than 90 countries. Key brands in its portfolio include Earol® and EarolSwim®, which provide clinically proven ENT care solutions. Venture Life's business model is centered on commercializing products that address the needs of an aging population and respond to pressures on global healthcare budgets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-03 17:40
Director's Dealing
Director/PDMR Shareholding
English 22.3 KB
2025-09-30 08:01
Transaction in Own Shares
Share Buyback Programme
English 14.1 KB
2025-09-29 13:19
Report Publication Announcement
Investor Presentation via Investor Meet Company
English 9.6 KB
2025-09-24 15:38
Report Publication Announcement
Change of Accounting Reference Date
English 10.4 KB
2025-09-08 08:00
Board/Management Information
Directorate Change
English 11.5 KB
2025-08-19 15:04
Major Shareholding Notification
Holding(s) in Company
English 22.0 KB
2025-08-05 16:43
Post-Annual General Meeting Information
Result of General Meeting
English 10.1 KB
2025-07-07 17:21
Director's Dealing
Director/PDMR Shareholding
English 22.1 KB
2025-07-03 08:00
Director's Dealing
Director Dealings
English 55.5 KB
2025-07-02 08:00
Pre-Annual General Meeting Information
Notice of General Meeting & Investor Presentation
English 11.8 KB
2025-07-01 17:08
Major Shareholding Notification
Holding(s) in Company
English 53.0 KB
2025-06-30 16:13
Earnings Release
Final Results for year ended 31 December 2024
English 559.9 KB
2025-05-19 08:01
Remuneration Information
Director Dealings
English 10.5 KB
2025-05-12 09:49
M&A Activity
Replacement: Cash sale of CDMO operations
English 27.4 KB
2025-02-20 14:14
Major Shareholding Notification
Holding(s) in Company
English 22.0 KB

Automate Your Workflow. Get a real-time feed of all VENTURE LIFE GROUP PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for VENTURE LIFE GROUP PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Fine Foods & Pharmaceuticals Ntm Logo
Contract development & manufacturing of oral solids for pharma, nutraceutical & cosmetic sectors.
Italy FF
Formycon AG Logo
Develops cost-effective biosimilars for ophthalmology, immunology, and other chronic diseases.
Germany FYB
Friulchem Logo
CDMO for animal health, providing vet pharma & supplement solutions for pets and livestock.
Italy FCM
Fuji Pharma Co.,Ltd. Logo
Specializes in hormone medicines for ob/gyn, injectables, and contract manufacturing.
Japan 4554
Fuso Pharmaceutical Industries,Ltd. Logo
Manufactures essential pharmaceuticals like dialysis drugs, infusions, and injections for healthcare.
Japan 4538
FutureChem Co., Ltd. Logo
Develops radiopharmaceuticals & diagnostic agents for cancer, Alzheimer's, and Parkinson's disease.
South Korea 220100
Future Medicine  Co., Ltd. Logo
Clinical-stage biopharma developing novel synthetic drugs for inflammation, fibrosis, and oncology.
South Korea 341170
Develops long-acting injectable therapies for chronic diseases and cancer.
South Korea 456160
Gabather AB Logo
Developing novel GABAA receptor drugs for neuropsychiatric disorders.
Sweden GABA
Galapagos NV Logo
Biotech firm developing novel CAR-T cell therapies for oncology via a rapid delivery platform.
Belgium GLPG

Talk to a Data Expert

Have a question? We'll get back to you promptly.